Immune system killer cells increase risk of diabetes

July 6, 2017, Max Planck Society

More than half of the German population is obese. One effect of obesity is to chronically activate the immune system, placing it under continuous stress. Researchers in Jens Brüning's team at the Max-Planck-Institute for Metabolism Research and at the University Hospital Cologne have discovered a subpopulation of immune cells in obese mice and humans that are involved in the development of diabetes. If this immune cell subpopulation could be specifically depleted in humans, the risk for diabetes development in overweight people might be reduced.

The rise of obesity in Germany has resulted in more diabetes and stroke patients. In addition, cancer rates are also increasing, as one effect of obesity is to chronically activate the immune system.

Scientists in Cologne therefore decided to study how the immune system responds to obesity and how related complications arise. This research brought their attention to a subpopulation of , so called natural killer (NK) cells. Normally the task of NK cells is to fight against virus-infected or . In obese mice, however, different genes are activated in a subgroup of NK cells compared to NK cells of normal-weight animals. This specific NK cell subgroup is involved in the increased activation of the immune system leading to more insulin resistance – the precursor of diabetes.

Diet reduces the risk for diabetes

The composition of NK cells in lean and obese subjects also varies in humans. Killer cells in blood samples from obese patients have a similar genetic profile compared to . "If our went on a strict diet, losing up to 30 kilograms, the number of altered also decreased, as well as the level of systemic inflammation and the risk for diabetes", explains Sebastian Theurich, physician scientist at the Max-Planck-Institute for Metabolism Research and a specialist in haematology and oncology at the Department I for Internal Medicine, University Hospital Cologne

In mice which received a highly fat-enriched diet, the researchers were also able to reduce the risk of diabetes by specific genetic modifications of NK cells, which prevented the development of this altered NK cell subpopulation. Without this NK cell subpopulation, the mice did not gain weight and insulin resistance to the same extent than control animals – notably, despite eating fatty food.

"This subpopulation of killer cells could provide an effective point of attack for new therapeutic approaches if we succeeded to selectively switch them off", explains Theurich. The scientists are therefore hoping to isolate markers that distinguish these specific killer from others, which would enable a targeted therapy.

Explore further: Scientists study how some insulin-producing cells survive in type 1 diabetes

More information: Sebastian Theurich et al. IL-6/Stat3-Dependent Induction of a Distinct, Obesity-Associated NK Cell Subpopulation Deteriorates Energy and Glucose Homeostasis, Cell Metabolism (2017). DOI: 10.1016/j.cmet.2017.05.018

Related Stories

Scientists study how some insulin-producing cells survive in type 1 diabetes

February 9, 2017
A Yale-led research team identified how insulin-producing cells that are typically destroyed in type 1 diabetes can change in order to survive immune attack. The finding may lead to strategies for recovering these cells in ...

Inflammatory signature of nonalcoholic fatty liver disease

May 16, 2017
A team of investigators led by Rohit Kohli, MBBS, MS, of Children's Hospital Los Angeles, has identified key inflammatory cells involved in nonalcoholic fatty liver disease. Current treatment for the disorder involves changes ...

Accelerated immune aging may contribute to obesity-linked metabolic disease

November 7, 2016
Obese individuals are at an elevated risk of developing comorbid cardiovascular and metabolic diseases, such as type 2 diabetes. Some research suggests that these comorbid diseases develop in response to chronic inflammation ...

Gamma-Delta T cells may play a role in insulin resistance and type 2 diabetes

January 5, 2015
New research in mice suggests that an unusual type of immune cell called "γδ T cells" may be a new drug and research target for treating or preventing type 2 diabetes caused by obesity. The research report, appearing in ...

Scientists discover how obesity stops 'guardian immune cells' from doing their job

March 2, 2017
Scientists have uncovered the physiological mechanics underlying inflammation and obesity by tracking the actions of 'guardian immune cells' in response to changes in diet. They believe their work may herald a new era of ...

Obesity reprogrammes muscle stem cells

February 22, 2017
Obesity is associated with reduced muscle mass and impaired metabolism. Epigenetic changes that affect the formation of new muscle cells may be a contributing factor, according to new research from Lund University, Sweden.

Recommended for you

Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes

December 11, 2018
Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes.

Millions of low-risk people with diabetes may be testing their blood sugar too often

December 10, 2018
For people with Type 2 diabetes, the task of testing their blood sugar with a fingertip prick and a drop of blood on a special strip of paper becomes part of everyday life.

Very low calorie diets trialled by NHS to tackle diabetes

December 7, 2018
Hundreds of thousands of people will receive NHS help to battle obesity and type 2 diabetes under radical action set out by Simon Stevens, Chief Executive of NHS England.

New therapeutic avenue for type 2 diabetes

December 6, 2018
Restoring the action of insulin is one of the keys to fighting type 2 diabetes. Researchers from Inserm led by Dominique Langin at the Institute of Cardiovascular and Metabolic Diseases (Inserm/Université de Toulouse) are ...

Subtype of immune B cells can delay type 1 diabetes onset in mice

December 6, 2018
A team of researchers at Baylor College of Medicine and the University of Michigan Medical School reports today in the JCI Insight that a subset of immune B cells, known as CD19+IgM+ B cells, can delay the onset of type 1 ...

Is the pancreas regeneration debate settled? An original theory renewed

December 5, 2018
A contentious debate among diabetes researchers has surrounded the regeneration of pancreatic insulin-producing cells: not if these cells regenerate, but rather how.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.